Document is current
Any future updates will be listed below
-
Authors
Anderson, Rhys
Lagnado, Anthony
Maggiorani, Damien https://orcid.org/0000-0002-3647-7383
Walaszczyk, Anna
Dookun, Emily
Chapman, James
Birch, Jodie
Salmonowicz, Hanna
Ogrodnik, Mikolaj
Jurk, Diana
Proctor, Carole
Correia‐Melo, Clara
Victorelli, Stella
Fielder, Edward
Berlinguer‐Palmini, Rolando https://orcid.org/0000-0002-1786-496X
Owens, Andrew
Greaves, Laura C
Kolsky, Kathy L
Parini, Angelo
Douin‐Echinard, Victorine
LeBrasseur, Nathan K
Arthur, Helen M
Tual‐Chalot, Simon
Schafer, Marissa J
Roos, Carolyn M
Miller, Jordan D
Robertson, Neil
Mann, Jelena
Adams, Peter D
Tchkonia, Tamara
Kirkland, James L
Mialet‐Perez, Jeanne https://orcid.org/0000-0002-1765-0283
Richardson, Gavin D https://orcid.org/0000-0002-2310-9987
Passos, João F https://orcid.org/0000-0001-8765-1890
-
Funding
Funding for this research was provided by:
Connor Group
Noaber Foundation
Région Occitanie, France
Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/K017314/1)
British Heart Foundation (PG/15/85/31744)
Foundation for the National Institutes of Health (AG013925)
- License Information
-
More Information
Article History
Received: 16 August 2018
Revised: 18 December 2018
Accepted: 2 January 2019
First Online: 8 February 2019
Conflict of interest
: Patents on INK‐ATTAC mice are held by Mayo Clinic and licensed to Unity Biotechnology. J.L.K. and T.T. may gain financially from these patents and licences. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. The remaining authors declare no competing financial interests.
